Bio-Rad Laboratories Inc. CI A (BIO) Social Stream
BIO-RAD LABORATORIES INC (BIO) Price Targets From Analysts
Use the tables below to see what analysts covering BIO-RAD LABORATORIES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 3 | $950 | $750 | $876.666 | $320.83 | 173.25% |
| 2022-02-11 | 3 | $930 | $750 | $820 | $320.83 | 155.59% |
| 2022-02-28 | 2 | $930 | $780 | $855 | $320.83 | 166.5% |
| 2022-05-02 | 2 | $930 | $700 | $793.333 | $320.83 | 147.28% |
| 2022-07-08 | 3 | $930 | $700 | $776.666 | $320.83 | 142.08% |
| 2022-07-31 | 2 | $700 | $700 | $700 | $320.83 | 118.18% |
| 2022-10-28 | 2 | $700 | $600 | $650 | $320.83 | 102.6% |
| 2022-12-07 | 2 | $700 | $565 | $621.666 | $320.83 | 93.77% |
| 2023-02-17 | 3 | $700 | $565 | $626.666 | $320.83 | 95.33% |
| 2023-05-08 | 3 | $605 | $525 | $553.666 | $320.83 | 72.57% |
| 2023-06-16 | 4 | $605 | $525 | $552.75 | $320.83 | 72.29% |
| 2023-08-07 | 4 | $560 | $524 | $533.5 | $320.83 | 66.29% |
| 2023-10-27 | 4 | $525 | $440 | $503.5 | $320.83 | 56.94% |
| 2023-12-07 | 5 | $525 | $395 | $481.8 | $320.83 | 50.17% |
The Trend in the Analyst Price Target
BIO's average price target has moved down $374.45 over the prior 27 months.
Over the past 42 weeks, BIO's average upside potential has been 49.11%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-08 | 3 | 605 | 525 | 565.000 | 378.39 | 49.32% |
| 2023-05-08 | 4 | 605 | 525 | 565.000 | 378.39 | 49.32% |
| 2023-05-08 | 4 | 605 | 525 | 553.666 | 378.39 | 46.32% |
| 2023-06-16 | 4 | 605 | 525 | 552.750 | 376.56 | 46.79% |
| 2023-08-07 | 4 | 560 | 524 | 533.500 | 401.52 | 32.87% |
BIO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
BIO's average broker recommendation rating worsened by 0.2 over the prior 43 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BIO as an investment opportunity.
- BIO has a higher average analyst price target than 1878.94% of all US stocks.
- In the context of stocks in the large market cap category, BIO-RAD LABORATORIES INC's number of analysts covering the stock is greater than 23.72% of them.
- BIO has a lower variance in analysts' estimates than -97.9% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of stocks in the large market cap category, BIO-RAD LABORATORIES INC's upside potential (average analyst target price relative to current price) is greater than 1695.52% of them.
In the Measuring and Control Equipment industry, KLAC, ITRI, and ST are the three stocks most similar to BIO-RAD LABORATORIES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BIO a Buy, Hold or Sell? See the POWR Ratings now!